One more detail is that Glioblast was registered only months before this deal. So its fair to say this payment may be brokerage. It makes it sound like this was a bio company and yes technically is correct. The thing since this Paul Hopper deal there have been no other deals in 5 years it seems the whole company rides on the back of one deal with Hopper. Having said that the guy is having lots of success. Maybe its a good deal but if you see his youtube videos he is very critical of some things. Worth a look.
With Platinum its just a rebalance of the portfolio they may be legally required to limit certain exposures in the interests of thier clients. This is a high risk speculation so a professional cannot do things like some and have dangerous weightings into KZA.
I have some exposure to Platinum full disclosure.
Good luck.
KZA Price at posting:
$1.28 Sentiment: Hold Disclosure: Held